Home Healthcare Biotechnology Gene Therapy Market

Gene Therapy Market Size, Share & Trends Analysis Report By Vector (Viral, Non-Viral), By Indication (Cancer, Cystic fibrosis, Heart diseases, Diabetes, Hemophiles, AIDS, Others), By Route of Administration (Intravenous, Inhalation) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: July 24, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Gene Therapy Market Size Analysis
    1. Introduction
    2. Gene Therapy Market Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
      1. Viral
        1. AAV
        2. Lentiviral vectors
        3. Others
      2. Non-Viral
    3. Gene Therapy Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Cancer
      2. Cystic fibrosis
      3. Heart diseases
      4. Diabetes
      5. Hemophiles
      6. AIDS
      7. Others
    4. Gene Therapy Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous
      2. Inhalation
  7. North America Gene Therapy Market Size Analysis
    1. Introduction
    2. Gene Therapy Market Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
      1. Viral
        1. AAV
        2. Lentiviral vectors
        3. Others
      2. Non-Viral
    3. Gene Therapy Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Cancer
      2. Cystic fibrosis
      3. Heart diseases
      4. Diabetes
      5. Hemophiles
      6. AIDS
      7. Others
    4. Gene Therapy Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous
      2. Inhalation
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
  8. Europe Gene Therapy Market Size Analysis
    1. Introduction
    2. Gene Therapy Market Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
      1. Viral
        1. AAV
        2. Lentiviral vectors
        3. Others
      2. Non-Viral
    3. Gene Therapy Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Cancer
      2. Cystic fibrosis
      3. Heart diseases
      4. Diabetes
      5. Hemophiles
      6. AIDS
      7. Others
    4. Gene Therapy Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous
      2. Inhalation
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    7. France
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
  9. APAC Gene Therapy Market Size Analysis
    1. Introduction
    2. Gene Therapy Market Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
      1. Viral
        1. AAV
        2. Lentiviral vectors
        3. Others
      2. Non-Viral
    3. Gene Therapy Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Cancer
      2. Cystic fibrosis
      3. Heart diseases
      4. Diabetes
      5. Hemophiles
      6. AIDS
      7. Others
    4. Gene Therapy Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous
      2. Inhalation
    5. China
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    8. India
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    10. Singapore
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    11. Taiwan
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    12. South East Asia
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    13. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
  10. Middle East and Africa Gene Therapy Market Size Analysis
    1. Introduction
    2. Gene Therapy Market Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
      1. Viral
        1. AAV
        2. Lentiviral vectors
        3. Others
      2. Non-Viral
    3. Gene Therapy Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Cancer
      2. Cystic fibrosis
      3. Heart diseases
      4. Diabetes
      5. Hemophiles
      6. AIDS
      7. Others
    4. Gene Therapy Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous
      2. Inhalation
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    11. The rest of MEA
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
  11. LATAM Gene Therapy Market Size Analysis
    1. Introduction
    2. Gene Therapy Market Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
      1. Viral
        1. AAV
        2. Lentiviral vectors
        3. Others
      2. Non-Viral
    3. Gene Therapy Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Cancer
      2. Cystic fibrosis
      3. Heart diseases
      4. Diabetes
      5. Hemophiles
      6. AIDS
      7. Others
    4. Gene Therapy Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Intravenous
      2. Inhalation
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Vector 2022-2034 (USD MILLION/ Units)
        1. Viral
          1. AAV
          2. Lentiviral vectors
          3. Others
        2. Non-Viral
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cystic fibrosis
        3. Heart diseases
        4. Diabetes
        5. Hemophiles
        6. AIDS
        7. Others
      4. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Intravenous
        2. Inhalation
  12. Competitive Landscape
    1. Gene Therapy Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Beacon Therapeutics
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Astellas Pharma Inc.
    3. Novartis AG
    4. Beam Therapeutics
    5. bluebird bio, Inc.
    6. Adverum Biotechnologies, Inc.
    7. Benitec Biopharma
    8. Oxford Biomedica PLC
    9. Sangamo Therapeutics
    10. uniQure N.V.
    11. Verve Therapeutics, Inc.
    12. CRISPR Therapeutics.
    13. Krystal Biotech, Inc. 
    14. Editas Medicine
    15. Taysha GTx
    16. Voyager Therapeutics, Inc.
    17. Sarepta Therapeutics, Inc.
    18. BioMarin Pharmaceutical Inc. 
    19. MeiraGTx Limited.
    20. Neurogene Inc.
    21. Others
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.